Literature DB >> 15710507

Polymeric micellar pH-sensitive drug delivery system for doxorubicin.

Martin Hrubý1, Cestmír Konák, Karel Ulbrich.   

Abstract

A novel polymeric micellar pH-sensitive system for delivery of doxorubicin (DOX) is described. Polymeric micelles were prepared by self-assembly of amphiphilic diblock copolymers in aqueous solutions. The copolymers consist of a biocompatible hydrophilic poly(ethylene oxide) (PEO) block and a hydrophobic block containing covalently bound anthracycline antibiotic DOX. The starting block copolymers poly(ethylene oxide)-block-poly(allyl glycidyl ether) (PEO-PAGE) with a very narrow molecular weight distribution (Mw/Mn ca. 1.05) were prepared by anionic ring opening polymerization using sodium salt of poly(ethylene oxide) monomethyl ether as macroinitiator and allyl glycidyl ether as functional monomer. The copolymers were covalently modified via reactive double bonds by the addition of methyl sulfanylacetate. The resulting ester subsequently reacted with hydrazine hydrate yielding polymer hydrazide. The hydrazide was coupled with DOX yielding pH-sensitive hydrazone bonds between the drug and carrier. The resulting conjugate containing ca. 3 wt.% DOX forms micelles with Rh(a)=104 nm in phosphate-buffered saline. After incubation in buffers at 37 degrees C DOX was released faster at pH 5.0 (close to pH in endosomes; 43% DOX released within 24 h) than at pH 7.4 (pH of blood plasma; 16% DOX released within 24 h). Cleavage of hydrazone bonds between DOX and carrier continues even after plateau in the DOX release from micelles incubated in aqueous solutions is reached.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15710507     DOI: 10.1016/j.jconrel.2004.11.017

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  31 in total

1.  Block copolymer micelles with acid-labile ortho ester side-chains: Synthesis, characterization, and enhanced drug delivery to human glioma cells.

Authors:  Rupei Tang; Weihang Ji; David Panus; R Noelle Palumbo; Chun Wang
Journal:  J Control Release       Date:  2010-12-29       Impact factor: 9.776

Review 2.  Endocytic mechanisms for targeted drug delivery.

Authors:  Lisa M Bareford; Peter W Swaan
Journal:  Adv Drug Deliv Rev       Date:  2007-06-28       Impact factor: 15.470

3.  Design and Development of Bioceramic Based Functionalized PLGA Nanoparticles of Risedronate for Bone Targeting: In-vitro Characterization and Pharmacodynamic Evaluation.

Authors:  Purnima Rawat; Kapil Manglani; Sarika Gupta; Abul Kalam; Divya Vohora; Farhan Jalees Ahmad; Sushama Talegaonkar
Journal:  Pharm Res       Date:  2015-04-04       Impact factor: 4.200

4.  The pH-induced thermosensitive poly (NIPAAm-co-AAc-co-HEMA)-g-PCL micelles used as a drug carrier.

Authors:  Weifeng Dai; Yan Zhang; Zhengzhen Du; Minliang Ru; Meidong Lang
Journal:  J Mater Sci Mater Med       Date:  2010-03-10       Impact factor: 3.896

5.  Poly(allyl glycidyl ether)-A versatile and functional polyether platform.

Authors:  Bongjae F Lee; Matthew J Kade; Jerred A Chute; Nalini Gupta; Luis M Campos; Glenn H Fredrickson; Edward J Kramer; Nathaniel A Lynd; Craig J Hawker
Journal:  J Polym Sci A Polym Chem       Date:  2011-10-15       Impact factor: 2.702

6.  Physiologically relevant, pH-responsive PEG-based block and statistical copolymers with N,N-diisopropylamine units.

Authors:  Annabelle Lee; Pontus Lundberg; Daniel Klinger; Bongjae F Lee; Craig J Hawker; Nathaniel A Lynd
Journal:  Polym Chem       Date:  2013       Impact factor: 5.582

7.  A drug-delivery vehicle combining the targeting and thermal ablation of HER2+ breast-cancer cells with triggered drug release.

Authors:  Jin-Oh You; Peng Guo; Debra T Auguste
Journal:  Angew Chem Int Ed Engl       Date:  2013-03-11       Impact factor: 15.336

8.  Physicochemical aspects of doxorubicin-loaded pH-sensitive polymeric micelle formulations from a mixture of poly(L-histidine)-b-poly(ethylene glycol)/poly(L-lactide)-b-poly(ethylene glycol) [corrected].

Authors:  Haiqing Yin; You Han Bae
Journal:  Eur J Pharm Biopharm       Date:  2008-08-22       Impact factor: 5.571

9.  Maurocalcine as a non toxic drug carrier overcomes doxorubicin resistance in the cancer cell line MDA-MB 231.

Authors:  Sonia Aroui; Narendra Ram; Florence Appaix; Michel Ronjat; Abderraouf Kenani; Fabienne Pirollet; Michel De Waard
Journal:  Pharm Res       Date:  2008-12-13       Impact factor: 4.200

10.  Doxorubicin loaded pH-sensitive micelle: antitumoral efficacy against ovarian A2780/DOXR tumor.

Authors:  Dongin Kim; Eun Seong Lee; Kyeongsoon Park; Ick Chan Kwon; You Han Bae
Journal:  Pharm Res       Date:  2008-05-01       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.